Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

A gene-based model predicts lung adenocarcinoma outcomes and helps guide treatment decisions.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Portable point-of-care testing can improve quick and accurate genetic disorder detection.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Promising cancer treatments were found, but the manufacturer closed.

The analysis of a large pilomatricoma revealed five distinct areas with different gene activity related to hair growth and tumor development.

New cancer treatments aim to reduce side effects and improve effectiveness.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Mitochondrial genes help predict breast cancer outcomes and spread.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Cancer prevention has advanced significantly, with some strategies proving successful.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Certain genetic variants increase the risk of aggressive prostate cancer.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Skin reactions from cancer treatments might predict how well the treatments work.